Control_No_Glycine_vs_SHMT2_Upregulated_No_Glycine

Control_No_Glycine vs SHMT2_Upregulated_No_Glycine

p-value ≤ 0.05 0 significant 2025-09-26 00:00:00 Study: MTBLS405
21 Total Features
0 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS405_0004_00000002
Linked study
MTBLS405 — Proteomic and metabolic changes in cancer cells after alternation of SHMT2 expressions
Comparison
Control_No_Glycine vs SHMT2_Upregulated_No_Glycine
Group A
Control group with no glycine treatment. Provides baseline for comparison with glycine-depleted and treated samples
Group B
SHMT2 upregulated group with no glycine treatment. Examines the effect of SHMT2 upregulation in glycine-depleted conditions
Total features tested
21
Significant features
0
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value